Service of Endocrinology and Metabolism, Clinic's Hospital, Federal University of Paraná, Curitiba, Paraná, Brazil.
Thyroid. 2013 Jul;23(7):779-84. doi: 10.1089/thy.2012.0435. Epub 2013 Jun 21.
Hypothyroidism is treated with oral levothyroxine. Some patients fail to attain adequate control because of poor compliance. Delaying breakfast to take levothyroxine on an empty stomach can decrease adherence to hypothyroidism treatment. The objective of this study was to evaluate whether administering levothyroxine with breakfast can maintain thyrotropin (TSH) levels in the therapeutic range, without major clinical changes.
A prospective, randomized, open-label, crossover study was conducted to compare usual levothyroxine administration while in a fasting state with administration during breakfast. From September 2008 to April 2009, 45 patients with primary hypothyroidism who received levothyroxine were recruited. The patients completed 180 days of the protocol and were randomized to 90 days of each levothyroxine administration regimen (while fasting or with breakfast). Clinical and biochemical analyses were performed at baseline and on days 45, 90, 135, and 180. The primary outcome was TSH level.
Forty-two patients completed the protocol. The TSH level was higher for levothyroxine administration with breakfast than while fasting (2.89 vs. 1.9 mIU/L, p=0.028). Uncontrolled hypothyroidism (TSH ≥3.5 mIU/L) occurred regardless of the type of levothyroxine administration (p=0.26). No risk factors were identified for TSH elevation.
Levothyroxine administration with breakfast could be an alternative regimen for patients who have adherence difficulties due to the need for delaying intake, and is more likely to cause variability in the TSH level, meaning the patient should be followed more closely. For patients in whom a specific serum TSH goal is important, taking levothyroxine while fasting is recommended.
甲状腺功能减退症采用口服左甲状腺素治疗。由于依从性差,一些患者无法获得充分控制。为了空腹服用左甲状腺素而延迟早餐会降低对甲状腺功能减退症治疗的依从性。本研究的目的是评估在早餐时服用左甲状腺素是否可以维持促甲状腺激素(TSH)水平在治疗范围内,而不会出现重大临床变化。
进行了一项前瞻性、随机、开放标签、交叉研究,以比较空腹服用左甲状腺素与早餐时服用左甲状腺素的常规治疗。从 2008 年 9 月至 2009 年 4 月,招募了 45 名接受左甲状腺素治疗的原发性甲状腺功能减退症患者。患者完成了 180 天的方案,并随机分为每天服用左甲状腺素的 90 天(空腹或早餐时)。在基线和第 45、90、135 和 180 天进行临床和生化分析。主要结局指标是 TSH 水平。
42 名患者完成了方案。早餐时服用左甲状腺素的 TSH 水平高于空腹时(2.89 对 1.9 mIU/L,p=0.028)。无论服用左甲状腺素的类型如何,都出现了无法控制的甲状腺功能减退症(TSH≥3.5 mIU/L)(p=0.26)。未发现 TSH 升高的危险因素。
对于因需要延迟摄入而导致依从性困难的患者,早餐时服用左甲状腺素可能是一种替代方案,并且更可能导致 TSH 水平的变化,这意味着患者应更密切地随访。对于需要特定血清 TSH 目标的患者,建议空腹服用左甲状腺素。